Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules

Differential diagnosis of well-differentiated hepatocellular carcinoma (WD-HCC) and high-grade dysplastic nodules (HGDNs) represents a challenge for pathologists. Several immunohistochemistry markers have been identified to distinguish hepatocellular carcinoma (HCC) from HGDNs. However, sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Qin, Zhang, Yurong, Wang, Ning, Jin, Guangzhi, Jin, Haojie, Gu, Dishui, Tao, Xuemei, Huo, Xisong, Ge, Tianxiang, Cong, Wenming, Wang, Cun, Qin, Wenxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466664/
https://www.ncbi.nlm.nih.gov/pubmed/25749520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466664/
https://www.ncbi.nlm.nih.gov/pubmed/25749520

Ejemplares similares